The Wuerzburg Hybridoma Library against the Drosophila brain represents a collection of around 200 monoclonal antibodies that bind to specific structures in the Drosophila brain. Here we describe the immunohistochemical staining patterns, the Western blot signals of one- and two-dimensional electrophoretic separation, and the mass spectrometric characterization of the target protein candidates recognized by the monoclonal antibodies aa2 and ab52 from the library. Analysis of a mutant of a candidate gene identified the Drosophila homolog of the Epidermal growth factor receptor Pathway Substrate clone 15 (Eps15) as the antigen for these two antibodies.
The Wuerzburg Hybridoma Library against the Drosophila brain represents a collection of around 200 monoclonal antibodies that bind to specific structures in the Drosophila brain. Here we describe the immunohistochemical staining patterns, the Western blot signals of one- and two-dimensional electrophoretic separation, and the mass spectrometric characterization of the target protein candidates recognized by the monoclonal antibodies aa2 and ab52 from the library. Analysis of a mutant of a candidate gene identified the Drosophila homolog of the Epidermal growth factor receptor Pathway Substrate clone 15 (Eps15) as the antigen for these two antibodies.
The generation of hybridomas was one of the milestones in
modern biology [1],
[2] leading to the production of
monoclonal antibodies (mAbs), one of the most
important tools in biology. Instead of remaining as
mere tools for research, mAbs have become
indispensible in therapeutics as well as diagnostics
[3]. Today mAbs are important
therapeutic agents for a wide variety of diseases
like cancers [4],
autoimmunity [5],
respiratory diseases [6], infectious diseases [7] and AIDS [8]. Currently mAbs represent
over 30% of all biological proteins
undergoing clinical trials and are the second
largest class of biodrugs after vaccines [9]–[11].
With the advent of more efficient, genetically
engineered antibodies [12]
this trend is expected to grow [13],
[14]. The advancement of
technology and the widespread applications of mAbs
led to the development of alternate methods of
production, like nonrodent hybridomas [15], plants [16], ascites [17] and bioreactors [18]. Soon after the production
of mAbs against specific proteins, mAbs were
randomly generated as ‘hybridoma
libraries’ against complex protein mixtures
from tissues or subcellular compartments [19]–[21].
The production of such libraries against the
Drosophila nervous system was
pioneered by the group of the late Seymour Benzer
[22], [23].
One such extensive hybridoma library, generated
against Drosophila brain homogenate
is the Wuerzburg Hybridoma Library [24], [25]. MAbs from this library can
be used as tools for cell-specific neuroanatomical
staining [24]
and, in favorable cases, for the identification of
novel brain proteins by either a
“candidate” or “from antibody to
gene” approach. By the candidate approach the
antigen of mAb nb33 which binds to pigment
dispersing factor (PDF) containing neurons was
identified as the PDF precursor protein (but not the
PDF itself) [25]. The approach “from
antibody to gene” has led to the discovery of
several novel synaptic proteins. Initially, target
proteins were identified by screening of cDNA
expression libraries for clones expressing proteins
with an epitope recognized by a given mAb. The
cysteine string protein (CSP) and its gene
(Csp) was discovered by mAb ab49
[26], the synapse-associated
protein of 47 kD (SAP-47) and its gene
(Sap47) was discovered by mAb
nc46 and later shown to be also recognized at a
different epitope by nb200 [25], [27]. More recently, protein
purification and mass spectrometry was used for the
identification of the protein Bruchpilot (BRP) and
its gene (brp) recognized by the
mAb nc82 [28],
[29]. In addition to the mAbs
generated against brain homogenate our hybridoma
library contains mAbs 3C11 and pok13 which were
generated against bacterially expressed
Drosophilasynapsin and
calbindin-32, respectively [30],
[31]. Besides these mAbs with
known targets the library contains a large
collection of mAbs which recognize different
structures like body tissues (eyes, muscles,
cuticula, perineureum, trachea) or cellular
compartments (cell-body layers, nucleus, membranes)
or small subsets of neurons, but whose target
proteins are unknown [25]. Only few antibodies with
unknown targets bind to synaptic neuropil. In line
with our long standing research focus on synaptic
proteins [26]–[31] we here describe the mAbs
aa2 and ab52, their binding to synaptic neuropil of
the adult brain, their immunohistochemical staining
of the synaptic boutons of larval motor neurons, and
the experiments leading to the identification of the
homologue of Epidermal growth factor receptor
Pathway Substrate clone 15 (Eps15) as the antigen
they recognize in the Drosophila
brain. Eps15 is a substrate for the tyrosine kinase
activity [32]
of the Epidermal Growth Factor Receptor (EGFR) and
contains Ca2+ binding EF hands,
which comprise the Eps15 homology (EH) domain [33]. Proteins containing EH
domains interact with partner proteins containing
the Asn-Pro-Phe (NPF) motif and play an important
role in synaptic vesicle recycling and receptor
endocytosis [34].
Materials and Methods
Fly strains
Unless indicated otherwise, Canton S (CS) was
used as the wild type for all experiments.
eps15 mutant
flies [35] were
kindly provided by H. Bellen.
Hybridoma cell culture, monoclonal antibody
production
Hybridoma clones were generated as described
earlier [24], [25]. For mAb production,
cryopreserved cell lines were thawed and cultured,
initially in 24 well Nunclon™Δ plates
(Nunc) with HT medium as described earlier [25]. 50 µl of fetal
bovine serum was added per well to facilitate the
initial growth of the thawed cells. Growth of
cells was monitored daily under an inverted
microscope (Zeiss). Upon proliferation after
2–3 days, 1 ml of actively growing cell
suspension was used to inoculate 5 ml HT medium in
50 ml T flasks (Greiner Bio) and further cultured
for 2 days. Thereafter fresh medium was provided
and after 2 more days cell density was determined
by Trypan Blue (Sigma) exclusion staining of cell
suspension using a Neubauer-counting chamber
(GLW). When the supernatant appeared yellowish
(cell density ∼106 cells/ml),
supernatant medium was withdrawn and centrifuged
at 2000 rpm for 5 min to pellet all cells and the
cell-free supernatant was tested for the presence
of antibodies to find the optimal dilution for a
reliable signal in western blots and/or
immunohistochemistry. Upon detection of an
antibody signal, the antibody producing cells were
further cultured for continued antibody production
until the cell density reached ∼106
cells/ml. At this stage they could be either split
into more flasks or used to inoculate larger
flasks (250 ml, 75 cm2, Grenier Bio).
Supernatant from larger flasks was withdrawn every
3 days.
Characterization of the monoclonal
antibodies
For the characterization of monoclonal antibodies
their isotype was determined by capture ELISA
using the ISO2-KT (Sigma) mouse monoclonal
isotyping kit following the manufacturer's
instructions. 5-Aminosalicylic acid (Sigma) was
used as substrate (1 mg/ml) in 0.02 M sodium
phosphate buffer (pH 6.8) with 0.01%
H2O2 (v/v). Isotype of a
given mAb was visually evident as development of
color by the chromogenic substrate with its
corresponding anti-isotype antibody. The isotype
was further confirmed by immunoassay based
Isoquick Strips (Envirologix) following the
manufacturer's instructions. For storage of
the monoclonal antibodies, suitably sized aliquots
of the culture supernatant were snap frozen in
liquid nitrogen and stored at −20°C.
However in case of IgM antibodies, which (like
IgG3) tend to aggregate upon freezing and thawing,
they were stored at 4°C by adding 0.02%
NaN3 (w/v) as antimicrobial agent.
Immunostaining of fly heads
Cryosections of adult fly heads were made
essentially as previously described [36]. Series of consecutive
sections were collected on subbed glass slides
(Menzel Gläser), thawed on the slide and
air-dried. The slides were blocked for 2 hr at RT
in a humid chamber with normal serum from the
species in which the secondary antibody was
generated (Vector Labs) diluted 1∶20 in 1x
PBST (phosphate buffered saline, pH 7.6 with
0.1% Triton-X100). Thereafter the sections
were incubated with primary mAbs (aa2 1∶2,
ab52 1∶5) in PBST at 4°C overnight in a
humid chamber. Excess primary mAb was removed and
the slides were washed three times for 20 min each
with PBST. The slides were incubated with Cy2
labeled α-mouse secondary Ab (diluted
1∶500 in PBST) and either DAPI (0.2
µg/ml) or Cy3 labeled anti-HRP (1∶500)
(Jackson Immuno Res. Inc.) at room temperature for
2 hrs (anti-HRP cross-reacts with a carbohydrate
epitope on Drosophila neuronal
membranes). After washing in PBST the sections
were permanently mounted with Vectashield®
(Vector Labs). Optical sections were obtained by a
confocal scanning microscope (Leica TCS-SP2).
Immunostaining of motorneuron
terminals
The procedure for obtaining larval nerve-muscle
preparations for immuno-labeling has recently been
described [37]. The ‘filets’
were blocked in 5% normal goat serum
(Vector Labs) in 1x PBST for 1 hour at RT with
gentle shaking. Thereafter the preparations were
incubated overnight in the primary antibody (mAB
aa2 diluted 1∶2, mAb ab52 (1∶2),
guinea pig anti-Eps15 antiserum (kindly provide by
H. Bellen) (1∶300) in PBST) at 4°C. Next
day the preparations were washed in 1x PBST',
once for 30 min and 4 times for 1 h each at room
temperature with gentle shaking. Then they were
incubated overnight in the
goat-α-mouse-Alexa488 and goat-α-guinea
pig Cy3 secondary antibodies (Invitrogen), both
diluted 1∶500 in the blocking solution at
4°C. Next, the preparations were washed 3
times in PBST for 20 min each at room temperature
with gentle shaking. The preparations were mounted
in Vectashield®. Images were acquired with a
confocal scanning microscope. The confocal stacks
were analyzed using the Fiji package [38] based on ImageJ [39], [40].
SDS-PAGE and Western blot
Samples were prepared in 1x LDS sample buffer
(Invitrogen) and resolved using the NuPAGE®
precast gel system (Invitrogen) by SDS-PAGE. In
brief, samples were run on Novex® Bis-Tris
12% gels with 1x MOPS SDS running buffer
(Invitrogen). Gels were transferred onto 0.45
µm nitrocellulose membrane (Protran®,
Whatman) with 3 mm Chr paper (Whatman) sandwiches
in a Mini Trans-Blot® (Bio-Rad) apparatus
using the Towbin buffer system [41] at 100 V for 1 hr.
Thereafter the membranes were stained with Ponceau
S (0.1% w/v) solution (Sigma) and blocked
in 5% (w/v) non-fat dry milk (Roth) in 1x
TBST (10 mM Tris pH 7.6, 150 mM NaCl, 0.05%
v/v Tween-20) for 2 hours at room temperature.
Thereafter blots were incubated overnight in
primary antibodies at suitable dilutions in 1x
TBST at 4°C. The mAb aa2 was used at dilution
of 1∶2 while ab52 was used at a dilution of
1∶10. Next morning, blots were washed in 1x
TBST three times for 5 minutes each and then
incubated for one hour with the
goat-α-mouse-HRP secondary antibody (Bio-Rad)
diluted at 1∶7500 in 1x TBST at room
temperature. Thereafter blots were washed as
earlier and developed with ECL™ (Amersham,
GE) and signals were obtained as exposures on
X-Ray films in the dark and developed them using
developing and fixing solutions (Kodak).
Subcellular fractionation
Adult CS flies were anesthetized with
CO2, collected in 50 ml falcon tubes
and snap frozen by immersing the tubes in liquid
N2. Frozen flies were vigorously
vortexed to separate all jointed body parts and
passed through a stack of two sieves. The upper
sieve with 800 µm mesh size retained thorax
and abdomen while the lower sieve with 500
µm mesh size retained the heads, and smaller
body parts passed through. Frozen heads from the
lower sieve were collected and pulverized in a
mortar-pestle, which was prechilled to
−80°C. The powder was dissolved in
homogenization buffer A (50 mM Tris, 150 mM NaCl,
1 mM EDTA, 1 mM EGTA final pH 7.3) supplemented
with 1 tablet (per 10 ml buffer per 1 gm of fly
heads) of protease inhibitors mix (Complete
Mini™, Roche). The sample was thoroughly
mixed to get a uniform homogenate, which was then
incubated on ice for 5 minutes. Thereafter it was
spun twice at 13000 rpm for 15 min each, at
4°C to pellet the exoskeleton, cell debris,
nuclei (P1). The post-nuclear supernatant (S1) was
re-spun in an ultracentrifuge (L8 Beckman, 60Ti
rotor) at 100000 g for 1 hr at 4°C to get the
cytosolic fraction as the supernatant (S2) and the
total membrane fraction as the pellet (P2) which
were then tested on Western blots.
Proteins from fly head homogenate were resolved
by 2D electrophoresis using the Zoom® 2D
(Invitrogen) setup. In brief, 100 freshly isolated
CS fly heads were homogenized in 100 µl of
Zoom® 2D Protein Solubilizer1 (Invitrogen)
containing 1x protease inhibitors
(Complete-Mini™, Roche). The homogenate was
then centrifuged at 13000 rpm for 15 min at
4°C, to remove the exoskeleton, cell debris,
and nuclei. 1 µl of 99%
N,N-Dimethylacrylamide (DMA, Sigma) was added to
the post-nuclear supernatant and incubated on a
rotary shaker at room temperature for 15 min to
alkylate the proteins. Thereafter 1 µl of 2
M DTT was added to quench any excess DMA and the
sample was ready for loading. 25 µl of this
homogenate, equivalent to 25 fly heads was mixed
with strip rehydration buffer (Zoom® 2D
Protein Solubilizer1, 20 mM DTT, traces of
Bromophenolblue) supplemented with 0.01%
(v/v) 3–10 pH ampholyte (Serva) to get a
final volume of 165 µl. Immobilized pH
gradient (IPG) (Zoom®, Invitrogen) strips for
the range 3–10 pH were rehydrated with this
sample as per the manufacturer's instructions
in the Zoom® IPG Runner™ cassette
overnight at 18°C. Next day the sample in the
rehydrated strips was resolved by isoelectric
focusing with a Zoom® Dual power supply unit
(Invitrogen), while keeping the power limited to
0.1 W per strip and using the voltage regime shown
in Table 1.
Table 1
Voltage regime for isoelectric
focusing.
Step
Voltage (V)
Time (min)
Total Volthours (Vh)
1
200
20
66.7
2
450
15
112.5
3
750
15
187.5
4
750–2000
45
468.75
5
2000
30
1000
Thereafter the strips were incubated in the
equilibration solution (1x NuPAGE™ LDS
sample buffer with 1x NuPAGE™ Reducing
Agent, both Invitrogen) and alkylation solutions
(1x NuPAGE™ LDS sample buffer) with 125 mM
Iodoacetamide (Sigma) for 15 minutes respectively,
with gentle shaking. Thereafter the strips were
loaded into the IPG well of 4–12%
Bis-Tris NuPAGE™ (Invitrogen) 2D PAA gel and
overlaid with agarose (0.5% w/v in 1x MOPS
running buffer). The second dimension was run at
100V after which proteins were blotted from the
gel on two separate membranes consecutively to get
duplicate blots of the same 2D separation profile.
These membranes were then incubated with the mAb
aa2 and ab52 separately and developed to compare
their signal profiles.
Two-dimensional electrophoresis
NEPHGE/SDS-PAGE
For separation of larger amounts of proteins,
Non-Equilibrium
pH
Gradient gel
Electrophoresis (NEPHGE)
was performed according to the method of
O'Farrell et al.
[42] with some modifications. In
brief, tube gels [9 M Urea, 4%
acrylamide, 2.5% NP40, 5% ampholytes
(Servalyte™, Serva) pH 2–11,
0.03% APS, 0.2% TEMED] of
length 11 cm and diameter 3 mm, were casted
overnight. Soluble (cytosolic) fraction S2 was
obtained as described above and 100 µl (100
head equivalents) were precipitated with 900
µl of chilled acetone for 3 hours at
−20°C. The sample was centrifuged at
10000 g for 10 min at 4°C to pellet the
precipitated proteins. The supernatant was
discarded, the pellet was air-dried and
resuspended in 50 µl sample loading buffer 1
(9.5 M Urea, 0.5% SDS, 5%
β-mercaptoethanol, 2% ampholytes pH
2–11). Upon dissolution, an equal volume of
buffer 2 (9.5 M Urea, 5% NP-40, 5%
β-mercaptoethanol, 2% ampholytes pH
2–11) was added. The sample was loaded on
top of the tube gel and overlaid with 40 µl
of overlaying solution (6 M Urea, 5% NP-40,
1% ampholytes pH 2–11).
Electrophoresis was carried out in the Model 175
Tube Cell (Bio-Rad) setup at 200 V for 15 min,
followed by 300 V for 30 min and finally at 400 V
for 120 min. 10 mM H3PO4 and
20 mM NaOH were used as anode and cathode
electrophoresis buffers respectively. As a marker
for highly basic proteins, cytochrome C having a
pI>11, was loaded on one of the tube gels as a
control for the progress of the 1st
dimension. At the end of the run, the NEPHGE gel
with the sample was slowly withdrawn from the
glass tube, equilibrated for 20 min with the SDS
sample buffer (60 mM Tris-HCl, 2% SDS,
5% β-mercaptoethanol, 10%
Glycerol, pH 6.8) and overlaid with 1%
agarose in SDS sample buffer on a 12% PAA
gel. 10 freshly homogenized fly heads were also
loaded in an adjacent lane to serve as a 1D
reference to the 2D profile. Electrophoresis was
carried out at 15 mA for 16 hr. The tube gel with
cytochrome C was cut into 0.5 cm pieces and each
piece was incubated overnight with 3 ml
dH2O at 4°C such that the pH along
the length of the gel could be measured next
morning.
Partial blot and silver staining of NEPHGE
gel
After 2DE, the gel was blotted for 20 minutes
using the Towbin transfer buffer system at 2
mA/cm2 of gel area in a
PerfectBlue™ (peqLAB) semi-dry blotting
apparatus. By this procedure only part of the
protein content of the gel was transferred onto
the membrane, while the rest was retained in the
gel, which was then silver stained for MS
compatibility as described earlier [43]. The blot was blocked as
described above and then incubated with primary
antibody (ab52, diluted 1∶10) and developed
as described above. Overnight exposure was done to
get a strong signal for the antigen along with
weak non-specific signals on the blot, which would
serve as landmarks for comparison with the
silver-stained gel. Images of the over-exposed
blot and the silver-stained gel were digitally
superimposed with Photoshop (Adobe) to pinpoint
the protein spot in the silver stained gel that
corresponded to the signal in the Western blot.
This spot was then excised and analyzed by mass
spectrometry as described below.
Immunoprecipitation of the antigen for mAb
aa2
3000 fly heads were homogenized in 1 ml of
homogenization buffer (50 mM Tris, 100 mM NaCl,
10% glycerol, 1% Triton X-100, 1.5
mM MgCl2, 0.01%
β-mercaptoethanol, protease inhibitors as in
buffer-A, final pH 7.5), centrifuged at 14000 rpm,
4°C for 10 min to yield the supernatant S1.
600 µl of protein-G agarose beads (Roche)
were washed in homogenization buffer and incubated
in 8 ml of undiluted mAb aa2 supernatant
(neutralized to pH 7.5 with 1 M
Na2HPO4) for 3 h at 4°C
with gentle mixing, followed by washing and
incubation with supernatant S1 for 3 h at 4°C.
The mixture was centrifuged (1500 rpm, 4°C, 2
min), the pellet was washed with 1 ml
homogenization buffer, and 60 µl of 5x
Lämmli buffer was added to the beads. The
sample was heat denatured and loaded in two gels
and resolved in parallel by SDS-PAGE. One gel was
stained by Coomassie [44]
while the other was blotted. The blot was blocked
as described earlier and incubated with the
primary antibody aa2 (1∶2), followed by
development as described above. Superimposition of
the stained gel and blot images allowed the
identification of the proteins bands in the
stained gel that corresponded to the Western blot
signal. The specific bands were excised and
analyzed by mass spectrometry as described
below.
Mass spectrometric (MS) analysis
The protein spot from the silver stained NEPHGE
gel, corresponding to the mAb ab52 Western signal,
and the Coomassie-stained immunoprecipitated
proteins in the 1-D SDS gel corresponding to the
mAb aa2 Western signal were excised and the
proteins were reduced, carbamidomethylated, and
digested by trypsin followed by MS analysis as
described earlier [25]. For data evaluation,
raw-data was converted to Mascot-mgf files using
ProteomeWizard (http://proteowizard.sourceforge.net/).Searches
were conducted against a subset of the Swissprot
database (www.uniprot.org) containing 35373
sequences (5th May 2011). Mascot (v2.2) was used
as search engine with Mascot Daemon support
(v2.2.0) with the following parameters: Trypsin
was set as protease with one miscleavage site
allowed, precursor and fragment ion tolerance was
0.5 Da, carbamidomethylation (C) was chosen as
fixed and oxidation (M) as variable modification.
Peptides with p<0.01 and scores above 38 were
considered for subsequent manual validation.
Results and Discussion
Characterization of the mAb isotypes
aa2 was found to be an IgG1, while ab52 was found
to be an IgM. The fact that aa2 and ab52 are of
different isotypes indicates that they are
produced by two distinct hybridoma cell lines and
hence not subclones from a common parent hybridoma
cell. Both mAbs had the kappa (κ) type of
light chain.
Staining pattern of the mAbs aa2 and
ab52
On cryosections of adult heads these two
antibodies equally stain all synaptic neuropil as
shown in Fig. 1A. In larval
nerve-muscle preparations both antibodies stain
all synaptic boutons (Fig. 1B,C).
Figure 1
Staining patterns of mAbs aa2 and
ab52.
(A) Cryosections of an adult fly head were
probed with mAb aa2 (left) and mAb ab52 (right).
Both antibodies stain all synaptic neuropil
(green) but not the surrounding the cell body
layer whose nuclei are stained with DAPI (blue).
(B, C) Synaptic boutons of larval motor neuron
terminals stained with anti-HRP (left, red) and
mAbs aa2 (B, middle, green), or ab52 (C, middle,
green). The overlays in the right column
demonstrate that the epitopes recognized by both
mAbs are present in all boutons (here shown for
muscles M12/13 (B) and muscles M6/7 (C)) but not
in the axons. Scale bars in A: 100 µm; in C
for B and C: 50 µm)
Staining patterns of mAbs aa2 and
ab52.
(A) Cryosections of an adult fly head were
probed with mAb aa2 (left) and mAb ab52 (right).
Both antibodies stain all synaptic neuropil
(green) but not the surrounding the cell body
layer whose nuclei are stained with DAPI (blue).
(B, C) Synaptic boutons of larval motor neuron
terminals stained with anti-HRP (left, red) and
mAbs aa2 (B, middle, green), or ab52 (C, middle,
green). The overlays in the right column
demonstrate that the epitopes recognized by both
mAbs are present in all boutons (here shown for
muscles M12/13 (B) and muscles M6/7 (C)) but not
in the axons. Scale bars in A: 100 µm; in C
for B and C: 50 µm)
Migration pattern of antigens recognized by
aa2 and ab52 on 1DE
In Western blots of freshly homogenized CS fly
heads, both antibodies produce a single signal
around 100 kDa. To test for identical migration
properties of the recognized antigens, proteins
from 2 freshly homogenized CS fly heads were
resolved by SDS-PAGE, followed by Western blotting
and then the blot of a single lane was vertically
cut into two halves. One half of the lane was
incubated with mAb aa2 and the other with mAb
ab52, both halves were separately washed,
incubated with secondary antibody, washed again
and then developed together (Fig. 2A). The
developed blots suggest that the antigens
recognized by the two mAbs have the same
Mr and hence may be the same
protein.
Figure 2
mAbs aa2 and ab52 recognize soluble
proteins at identical Mr on 1D Western
blot.
(A) Blot of a single SDS gel electrophoresis
lane loaded with homogenate from 2 wild-type (CS)
heads. The blotted membrane was vertically cut in
two halves; one was developed with mAb aa2 (left),
the other with mAb ab52 (right). Signals at
identical Mr suggests that both mAbs
probably recognize the same antigen. (B) Western
blot of subcellular fractions of wild-type (CS)
fly heads showing that the protein detected by mAb
ab52 is exclusively present in the cytosolic
supernatant. S1 =
postnuclear supernatant; S2
= cytosolic fraction; P2
= total membrane fraction
(10 head equivalents loaded per lane). The
synaptic vesicle protein CSP recognized by the mAb
ab49 was used as a marker for the total membrane
fraction.
mAbs aa2 and ab52 recognize soluble
proteins at identical Mr on 1D Western
blot.
(A) Blot of a single SDS gel electrophoresis
lane loaded with homogenate from 2 wild-type (CS)
heads. The blotted membrane was vertically cut in
two halves; one was developed with mAb aa2 (left),
the other with mAb ab52 (right). Signals at
identical Mr suggests that both mAbs
probably recognize the same antigen. (B) Western
blot of subcellular fractions of wild-type (CS)
fly heads showing that the protein detected by mAb
ab52 is exclusively present in the cytosolic
supernatant. S1 =
postnuclear supernatant; S2
= cytosolic fraction; P2
= total membrane fraction
(10 head equivalents loaded per lane). The
synaptic vesicle protein CSP recognized by the mAb
ab49 was used as a marker for the total membrane
fraction.
Subcellular fractionation of ab52
antigen
Upon subcellular fractionation as described in
Materials and
Methods, the mAb ab52 antigen remained in
the cytosolic supernatant (S2), indicating that it
is soluble under the conditions of homogenization
(Fig
2B). CSP (cysteine string protein) detected
by mAb ab49 [26], remains in the pellet,
which represents the total membrane fraction, thus
demonstrating the effectiveness of the
fractionation.
Migration pattern of antigens recognized by
aa2 and ab52 on 2DE
Since aa2 and ab52 seemed to recognize the same
antigen on 1DE and since the antigen recognized by
ab52 was found to be a soluble, cytosolic protein,
we used 2DE to resolve this protein as a distinct
spot and compared the Western blots signals of the
2DE profile for both mAbs aa2 and ab52. CS fly
head homogenates were resolved by 2DE
(IEF/SDS-PAGE) followed by partial Western blot of
the same gel consecutively on two separate
membranes to get duplicate blots of the same 2DE
separation profile. Development of the blots
incubated with aa2 and ab52 separately, revealed
signals for both antibodies as a single, distinct
spot with identical patterns having Mr
∼100 kDa in the pI range 6–7 as shown in
Fig
3. This further indicated that both mAbs
indeed recognize the same antigen.
Figure 3
aa2 and ab52 produce signals at identical
Mr and pI on 2D Western blot
profile.
Two sequential Western blots from a single 2DE
gel loaded with sample equivalent to 25 fly heads.
The two membranes were cut along the horizontal
white line, the upper parts were developed with
mAbs aa2 (left, dilution 1∶2) or ab52
(right, dilution 1∶10), the lower parts were
stained with mAbs 3C11 (anti-SYN, 1∶100) and
nc46 (anti-SAP47, 1∶200) as controls for
both blots.
aa2 and ab52 produce signals at identical
Mr and pI on 2D Western blot
profile.
Two sequential Western blots from a single 2DE
gel loaded with sample equivalent to 25 fly heads.
The two membranes were cut along the horizontal
white line, the upper parts were developed with
mAbs aa2 (left, dilution 1∶2) or ab52
(right, dilution 1∶10), the lower parts were
stained with mAbs 3C11 (anti-SYN, 1∶100) and
nc46 (anti-SAP47, 1∶200) as controls for
both blots.
Enrichment of the antigen of mAb aa2 by
immunoprecipitation
mAb aa2 was used to enrich the target antigen it
recognized by immunoprecipitation (IP) to
facilitate its identification by MS. Homogenized
fly heads were subjected to immunoprecipitation
using serum-free supernatant and protein G beads
as described in Materials and Methods. Identical aliquots
of the S1 input to the IP, of the proteins eluted
from the beads by SDS buffer, and of homogenate
from 3 fresh heads were loaded in two gels, one
was Coomassie stained and one was blotted and
developed with mAb aa2. Among numerous bands in
the Coomassie-stained gel, one band appeared to
correspond to the mAb aa2 signal in the Western
blot (boxed in Fig. 4). Note that
in lane 3′ compared to lane 2′ of the
gel a tenfold higher amount of protein was loaded,
leading to the recognition of proteolytic
degradation products of the aa2 antigen in the
blot lane 3′.
Figure 4
Identification of mAb aa2 antigen by
comparison of a Coomassie stained gel and a
Western blot.
Coomassie-blue stained gel (left) and Western
blot of a gel run in parallel (right). Loaded was:
supernatant S1 (3 head equivalents, lanes 1,
1′), immunoprecipitation of S1 with mAb aa2
and protein-G beads (∼80 head equivalents,
lanes 2, 2′ or ∼800 head equivalents,
lanes 3, 3′), and 3 heads homogenized in
Lämmli buffer (lanes 4, 4′). The blot
was developed with mAb aa2. LC, light chain, HC,
heavy chain of mAb aa2. The boxed bands of the gel
were cut out and subjected to MS analysis.
Identification of mAb aa2 antigen by
comparison of a Coomassie stained gel and a
Western blot.
Coomassie-blue stained gel (left) and Western
blot of a gel run in parallel (right). Loaded was:
supernatant S1 (3 head equivalents, lanes 1,
1′), immunoprecipitation of S1 with mAb aa2
and protein-G beads (∼80 head equivalents,
lanes 2, 2′ or ∼800 head equivalents,
lanes 3, 3′), and 3 heads homogenized in
Lämmli buffer (lanes 4, 4′). The blot
was developed with mAb aa2. LC, light chain, HC,
heavy chain of mAb aa2. The boxed bands of the gel
were cut out and subjected to MS analysis.
Enrichment of the antigen of mAb ab52 by
NEPHGE followed by SDS PAGE
mAb ab52 was found to be an IgM, making its
application in IP for enrichment of its target
antigen unsuitable. However the soluble nature of
the antigen allowed us to resolve it as a distinct
spot by 2DE. Thus the cytosolic supernatant (S2)
was subjected to
Non-Equilibrium
pH Gradient gel
Electrophoresis (NEPHGE)
followed by SDS-PAGE as described in
Western blotting (Fig. 5A) was done
for only 20 min, to transfer only part of the
total protein content of the gel onto the
membrane, while retaining the rest of it in the
gel, which was later visualized by MS-compatible
silver staining (Fig 5B). The blot
was incubated with mAb ab52 and developed with a
long exposure of 2 hours to obtain the specific
signal for ab52 and in addition, some non-specific
spots (Fig. 5A). The
non-specific spots on the Western blot were
numbered 1′–6′ and their
corresponding spots on the gel were numbered
1–6. These pairs of spots were used to align
the blot to the silver-stained gel and thus
pinpoint the silver-stained spot (circled in Fig.
5B) corresponding to the mAb ab52 antigen
signal in the Western blot.
Figure 5
Enrichment of the ab52 antigen for MS by
NEPHGE/SDS-PAGE and its final identification as
Eps15.
(A) Western blot developed with mAb ab52 after
partial transfer of proteins from the gel shown in
(B). The signal from the mAb ab52 can be clearly
seen as a distinct spot ∼100 kDa (asterisk),
with a corresponding strong signal in the 1D lane
loaded with 10 freshly homogenized fly heads.
Non-specific signals were numbered as landmarks
1′–6′. (B) Silver stained NEPHGE
gel with protein spots corresponding to the
non-specific Western signals of (A) numbered
1–6 and the spot corresponding to the
Western signal from mAb ab52 (encircled). (C)
Western Blot developed with mAbs ab52 and ab49
showing that in the Eps15 null mutant
eps15 the
∼100 kDa signal characteristic for ab52 in the
wild type (CS) is absent. CSP recognized by mAb
ab49 was used as a loading control.
Enrichment of the ab52 antigen for MS by
NEPHGE/SDS-PAGE and its final identification as
Eps15.
(A) Western blot developed with mAb ab52 after
partial transfer of proteins from the gel shown in
(B). The signal from the mAb ab52 can be clearly
seen as a distinct spot ∼100 kDa (asterisk),
with a corresponding strong signal in the 1D lane
loaded with 10 freshly homogenized fly heads.
Non-specific signals were numbered as landmarks
1′–6′. (B) Silver stained NEPHGE
gel with protein spots corresponding to the
non-specific Western signals of (A) numbered
1–6 and the spot corresponding to the
Western signal from mAb ab52 (encircled). (C)
Western Blot developed with mAbs ab52 and ab49
showing that in the Eps15 null mutant
eps15 the
∼100 kDa signal characteristic for ab52 in the
wild type (CS) is absent. CSP recognized by mAb
ab49 was used as a loading control.
Mass spectrometric identification of the
antigen candidates
The bands cut out from the gel of the IP
experiment (boxed in Fig. 4) were
analyzed by mass spectrometry after proteolytic
digestion and signals were matched. As is common
for 1D-PAGE separations, several different
Drosophila proteins were
identified in each band, of which 12 had a
score>300 (Table 2). Three of
the identified proteins are known components of
the peri-active zone of
Drosophila synapses and thus in
view of the localization data are preferred
candidates: Eps15, shibire (dynamin) and
α-adaptin. Furthermore, Dap160 was identified
as a low scoring but significant component of lane
3 (score 83, 3 peptides matched). For a detailed
list of all identified proteins please refer to
table S1.
Dap160/intersectin is a prominent binding partner
of Eps15 [35].
This suggests that one of these proteins could be
the desired antigen while the other three may have
been co-immunoprecipitated and, due to similar
molecular weights, enriched in the cut-out gel
pieces.
Table 2
Proteins with cumulative Mascot
scores>300 identified in the gel pieces boxed
in lane 2 and 3 of Fig. 4.
Protein identifications marked with asterisks
(*) featured several different accession
entries which belonged to the same protein but
isoforms were not resolvable. Accessions are given
in Swiss-Prot format.
Protein identifications marked with asterisks
(*) featured several different accession
entries which belonged to the same protein but
isoforms were not resolvable. Accessions are given
in Swiss-Prot format.The gel piece analyzed from the NEPHGE 2D gel
(encircled in Fig. 5B) contained
proteins which could be matched to three entries
of the of the Drosophila proteome
(Table 3). Since Hsc70Cb and Bicaudal D
have not been reported to match to the synaptic
neuropil or the synaptic localization of the mAb
ab52 antigen these proteins presumably are false
positive hits leaving Eps15 as a strong candidate.
We next demonstrated that a Western blot of an
adult eps15
null mutant escaper produced no signal with mAb
ab52 but normal SAP47 loading control signals
(Fig.
5C) and that
eps15 null
mutant larvae showed no synaptic neuropil staining
with mAbs aa2 or ab52 (Fig. 6A,B). Note
that with mAb ab52 there is a gradient of staining
intensity from the periphery to the center of the
neuropil, indicating the (large) IgM penetrates
whole mounts less easily than the IgG aa2.
Finally, we show that the immunohistochemical
signals generated within synaptic boutons of
larval nerve-muscle preparations by mAb aa2
exactly match the signals generated by anti-Eps15
antiserum (Fig. 6C).
Table 3
Proteins identified in the gel piece
encircled in Fig. 5B.
Verification of the prime candidate from
MS, EPS15, as the antigen recognized by mAbs aa2
and ab52.
Immunohistochemical staining of larval synaptic
neuropil with mAbs aa2 (A) and ab52 (B) is present
in wild type (WT) but absent in
eps15 null
mutants (Δ29) and perfectly matches the
distribution of Eps15 in synaptic boutons, here
shown on muscle M13 (C). Scale bar in A for A and
B: 100 µm; in C: 5 µm.
Verification of the prime candidate from
MS, EPS15, as the antigen recognized by mAbs aa2
and ab52.
Immunohistochemical staining of larval synaptic
neuropil with mAbs aa2 (A) and ab52 (B) is present
in wild type (WT) but absent in
eps15 null
mutants (Δ29) and perfectly matches the
distribution of Eps15 in synaptic boutons, here
shown on muscle M13 (C). Scale bar in A for A and
B: 100 µm; in C: 5 µm.We thus conclude that mAbs aa2 and ab52 of the
Würzburg Hybridoma Library indeed recognize
the same protein, Eps15 of
Drosophila, a protein of the
peri-active zone required for normal synaptic
bouton development and synaptic vesicle recycling
[34], [35],
[45], [46]. The two mAbs are of
different isotypes produced by two distinct
hybridoma lines. mAb aa2 being an IgG1 is more
suitable for applications like whole mount
stainings and immunoprecipitation (IgMs usually do
not bind to protein-A or –G), while for
immunostainings on sections or motor neuron
terminals and Western blots mAb ab52 (being an
IgM) is also suitable.Extended MS results for boxed bands from
lane 2 and 3 and for
encircled spot of 2DE gel in(XLS)Click here for additional data file.